• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Longitudinal Viral Suppression Among a Cohort of Adolescents and Young Adults with Behaviorally Acquired Human Immunodeficiency Virus.一组通过行为感染人类免疫缺陷病毒的青少年和青年中的病毒长期抑制情况
AIDS Patient Care STDS. 2017 Sep;31(9):377-383. doi: 10.1089/apc.2017.0078.
2
Long-term virologic responses to antiretroviral therapy among HIV-positive patients entering adherence clubs in Khayelitsha, Cape Town, South Africa: a longitudinal analysis.南非开普敦凯萨泰地区艾滋病毒阳性患者加入依顺俱乐部后,接受抗反转录病毒疗法的长期病毒学应答:纵向分析。
J Int AIDS Soc. 2020 May;23(5):e25476. doi: 10.1002/jia2.25476.
3
Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy.与抗逆转录病毒治疗6个月时测量病毒载量相比,在3个月时测量病毒载量可获得更好的病毒学和治疗结果。
J Int AIDS Soc. 2015 Sep 23;18(1):20092. doi: 10.7448/IAS.18.1.20092. eCollection 2015.
4
Assessment of antiretroviral third agent virologic durability after initiation of first antiretroviral regimen.首次抗逆转录病毒治疗方案启动后抗逆转录病毒第三种药物病毒学持久性的评估。
Int J STD AIDS. 2019 Jun;30(7):680-688. doi: 10.1177/0956462418815292. Epub 2019 May 1.
5
Higher Risks of Virologic Failure and All-Cause Deaths Among Older People Living with HIV in Chongqing, China.中国重庆老年HIV感染者病毒学失败和全因死亡风险更高。
AIDS Res Hum Retroviruses. 2019 Nov/Dec;35(11-12):1095-1102. doi: 10.1089/AID.2019.0096. Epub 2019 Oct 29.
6
Effect of gender and calendar year on time to and duration of virologic suppression among antiretroviral-naïve HIV-infected individuals initiating combination antiretroviral therapy.性别和年份对初治HIV感染个体开始联合抗逆转录病毒治疗后实现病毒学抑制的时间及持续时间的影响。
HIV Clin Trials. 2010 Nov-Dec;11(6):340-50. doi: 10.1310/hct1106-340.
7
Incidence of Postsuppression Virologic Rebound in Perinatally HIV-Infected Asian Adolescents on Stable Combination Antiretroviral Therapy.接受稳定联合抗逆转录病毒治疗的围产期感染艾滋病毒的亚洲青少年中抑制后病毒学反弹的发生率
J Adolesc Health. 2017 Jul;61(1):91-98. doi: 10.1016/j.jadohealth.2017.01.014. Epub 2017 Mar 24.
8
First-line antiretroviral therapy durability in a 10-year cohort of naïve adults started on treatment in Uganda.乌干达初治成年患者10年队列中一线抗逆转录病毒疗法的持久性
J Int AIDS Soc. 2016 Jun 17;19(1):20773. doi: 10.7448/IAS.19.1.20773. eCollection 2016.
9
Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation.在一组 HIV 阳性患者中,持续低水平病毒血症后的病毒学失败:12 年观察结果。
Clin Infect Dis. 2013 Nov;57(10):1489-96. doi: 10.1093/cid/cit529. Epub 2013 Aug 14.
10
Persistent Low-level Viremia Predicts Subsequent Virologic Failure: Is It Time to Change the Third 90?持续低水平病毒血症预测随后的病毒学失败:是否是时候改变第三个 90 了?
Clin Infect Dis. 2019 Aug 16;69(5):805-812. doi: 10.1093/cid/ciy989.

引用本文的文献

1
Sexual orientation, gender identity and virologic failure among people with HIV: a cohort study in all of US research program.艾滋病毒感染者的性取向、性别认同和病毒学失败:美国所有研究计划中的一项队列研究。
BMC Public Health. 2024 Aug 2;24(1):2091. doi: 10.1186/s12889-024-19559-7.
2
iVY: protocol for a randomised clinical trial to test the effect of a technology-based intervention to improve virological suppression among young adults with HIV in the USA.iVY:一项随机临床试验的方案,旨在测试一项基于技术的干预措施在美国年轻 HIV 感染者中提高病毒学抑制的效果。
BMJ Open. 2023 Oct 6;13(10):e077676. doi: 10.1136/bmjopen-2023-077676.
3
The development of social capital in a peer-led mHealth cognitive behavioral antiretroviral therapy adherence intervention for HIV + adolescents and young adults.同伴主导的移动医疗认知行为抗逆转录病毒治疗依从性干预措施对艾滋病毒感染者青少年和年轻人的社会资本发展。
AIDS Care. 2024 Apr;36(4):425-431. doi: 10.1080/09540121.2023.2262981. Epub 2023 Oct 5.
4
Durable Viral Suppression Among Young Adults Living with HIV Receiving Ryan White Services in New York City.在纽约市接受 Ryan White 服务的 HIV 感染者中的年轻成年人的持久病毒抑制。
AIDS Behav. 2023 Oct;27(10):3197-3205. doi: 10.1007/s10461-023-04040-0. Epub 2023 Apr 21.
5
Feasibility and Acceptability of the Adherence Connection Counseling, Education, and Support (ACCESS) Proof of Concept: A Peer-Led, Mobile Health (mHealth) Cognitive Behavioral Antiretroviral Therapy (ART) Adherence Intervention for HIV-Infected (HIV+) Adolescents and Young Adults (AYA).采用同伴主导、移动健康(mHealth)认知行为抗逆转录病毒疗法(ART)依从性干预措施对感染艾滋病毒(HIV+)的青少年和年轻成年人(AYA)进行依从性连接咨询、教育和支持(ACCESS)概念验证的可行性和可接受性。
AIDS Behav. 2023 Jun;27(6):1807-1823. doi: 10.1007/s10461-022-03913-0. Epub 2022 Dec 27.
6
A Mobile Health App (WYZ) for Engagement in Care and Antiretroviral Therapy Adherence Among Youth and Young Adults Living With HIV: Single-Arm Pilot Intervention Study.一款用于促进感染艾滋病毒的青年和年轻成年人参与护理及坚持抗逆转录病毒治疗的移动健康应用程序(WYZ):单臂试点干预研究。
JMIR Form Res. 2021 Aug 31;5(8):e26861. doi: 10.2196/26861.
7
Correlates of High HIV Viral Load and Antiretroviral Therapy Adherence Among Viremic Youth in the United States Enrolled in an Adherence Improvement Intervention.在美国参加依从性改善干预的病毒血症青年中,高HIV病毒载量与抗逆转录病毒疗法依从性的相关因素。
AIDS Patient Care STDS. 2021 May;35(5):145-157. doi: 10.1089/apc.2021.0005.
8
Substance Use Predicts Sustained Viral Suppression in a Community Cohort of Sexual and Gender Minority Youth Living with HIV.物质使用可预测感染艾滋病毒的性少数和性别少数青年社区队列中的持续病毒抑制。
AIDS Behav. 2021 Oct;25(10):3303-3315. doi: 10.1007/s10461-021-03179-y. Epub 2021 Feb 13.
9
Video-Counseling Intervention to Address HIV Care Engagement, Mental Health, and Substance Use Challenges: A Pilot Randomized Clinical Trial for Youth and Young Adults Living with HIV.视频咨询干预以应对艾滋病病毒护理参与、心理健康和物质使用挑战:一项针对感染艾滋病病毒的青少年和青年成年人的试点随机临床试验。
Telemed Rep. 2021 Jan 7;2(1):14-25. doi: 10.1089/tmr.2020.0014. eCollection 2021.
10
Adherence Self-Management and the Influence of Contextual Factors Among Emerging Adults With Human Immunodeficiency Virus.新兴人类免疫缺陷病毒感染者的坚持自我管理和情境因素的影响。
Nurs Res. 2020 May/Jun;69(3):197-209. doi: 10.1097/NNR.0000000000000422.

本文引用的文献

1
For Many Served By The Ryan White HIV/AIDS Program, Disparities In Viral Suppression Decreased, 2010-14.2010 - 2014年,接受瑞安·怀特艾滋病毒/艾滋病项目服务的许多人在病毒抑制方面的差距有所缩小。
Health Aff (Millwood). 2017 Jan 1;36(1):116-123. doi: 10.1377/hlthaff.2016.0655.
2
Racial and Ethnic Disparities in Preventable Hospitalizations for Chronic Disease: Prevalence and Risk Factors.慢性疾病可预防住院的种族和民族差异:患病率和风险因素。
J Racial Ethn Health Disparities. 2017 Dec;4(6):1100-1106. doi: 10.1007/s40615-016-0315-z. Epub 2016 Dec 6.
3
Antiretroviral Therapy for the Prevention of HIV-1 Transmission.抗逆转录病毒疗法预防HIV-1传播
N Engl J Med. 2016 Sep 1;375(9):830-9. doi: 10.1056/NEJMoa1600693. Epub 2016 Jul 18.
4
Predictors and Profiles of Antiretroviral Therapy Adherence Among African American Adolescents and Young Adult Males Living with HIV.感染艾滋病毒的非裔美国青少年和年轻成年男性抗逆转录病毒治疗依从性的预测因素及特征
AIDS Patient Care STDS. 2016 Jul;30(7):324-38. doi: 10.1089/apc.2015.0351.
5
Disparities in achieving and sustaining viral suppression among a large cohort of HIV-infected persons in care - Washington, DC.华盛顿特区一大群接受治疗的艾滋病毒感染者在实现和维持病毒抑制方面存在差异。
AIDS Care. 2016 Nov;28(11):1355-64. doi: 10.1080/09540121.2016.1189496. Epub 2016 Jun 13.
6
The Use of Mobile Health Applications Among Youth and Young Adults Living with HIV: Focus Group Findings.感染艾滋病毒的青年和年轻成年人对移动健康应用程序的使用:焦点小组研究结果
AIDS Patient Care STDS. 2016 Jun;30(6):254-60. doi: 10.1089/apc.2016.0044. Epub 2016 May 23.
7
Structural Determinants of Antiretroviral Therapy Use, HIV Care Attendance, and Viral Suppression among Adolescents and Young Adults Living with HIV.感染艾滋病毒的青少年和青年使用抗逆转录病毒疗法、接受艾滋病毒护理以及实现病毒抑制的结构决定因素
PLoS One. 2016 Apr 1;11(4):e0151106. doi: 10.1371/journal.pone.0151106. eCollection 2016.
8
An Index of Multiple Psychosocial, Syndemic Conditions Is Associated with Antiretroviral Medication Adherence Among HIV-Positive Youth.多种心理社会综合征状况指数与HIV阳性青年的抗逆转录病毒药物依从性相关。
AIDS Patient Care STDS. 2016 Apr;30(4):185-92. doi: 10.1089/apc.2015.0328.
9
Using a Mobile Health Intervention to Support HIV Treatment Adherence and Retention Among Patients at Risk for Disengaging with Care.使用移动健康干预措施来支持有脱离治疗风险的患者坚持接受HIV治疗并保持治疗。
AIDS Patient Care STDS. 2016 Apr;30(4):178-84. doi: 10.1089/apc.2016.0025.
10
The Impact of Youth-Friendly Structures of Care on Retention Among HIV-Infected Youth.青少年友好型护理结构对艾滋病毒感染青少年留存率的影响。
AIDS Patient Care STDS. 2016 Apr;30(4):170-7. doi: 10.1089/apc.2015.0263. Epub 2016 Mar 16.

一组通过行为感染人类免疫缺陷病毒的青少年和青年中的病毒长期抑制情况

Longitudinal Viral Suppression Among a Cohort of Adolescents and Young Adults with Behaviorally Acquired Human Immunodeficiency Virus.

作者信息

Wood Sarah M, Lowenthal Elizabeth, Lee Susan, Ratcliffe Sarah J, Dowshen Nadia

机构信息

1 Craig-Dalsimer Division of Adolescent Medicine, Children's Hospital of Philadelphia , Philadelphia, Pennsylvania.

2 Department of Pediatrics, University of Pennsylvania Perelman School of Medicine , Philadelphia, Pennsylvania.

出版信息

AIDS Patient Care STDS. 2017 Sep;31(9):377-383. doi: 10.1089/apc.2017.0078.

DOI:10.1089/apc.2017.0078
PMID:28891717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5610408/
Abstract

Youth living with HIV (YLWH) are less likely than older adults to achieve and sustain viral suppression. While treatment guidelines recommend decreased viral load (VL) monitoring in individuals with well-controlled HIV, the appropriateness of this strategy for adolescents is unknown. We conducted a retrospective cohort study to describe longitudinal viral suppression and identify incidence of, and risk factors for, virologic failure among YLWH at a US adolescent HIV clinic from 2002 to 2015. We utilized Cox proportional hazards modeling to compare hazard ratios (HRs) for virologic failure stratified by baseline characteristics. Study participants (n = 365) were predominately African American (87%) and cisgender men and transgender women who have sex with men (80%) and the majority (79%) entered care from 2002 to 2012. Of antiretroviral therapy (ART)-treated participants (n = 201), 88% achieved viral suppression, with 29% subsequently developing virologic failure at a median 12.0 months [interquartile range (IQR) 6.9-22.4] after suppression. The cohort incidence rate of virologic failure was 200 (confidence interval [95% CI]: 151-264) per 1000 person years (PY), with a rate after ≥2 years sustained suppression of 113 (95% CI: 57-227) per 1000 PY. After adjusting for time to ART initiation, initial regimen class, and year of cohort entry, cisgender women had increased hazards of virologic failure (HR 3.2 95% CI: 1.3-7.9, p = 0.01). In conclusion, youth remained at high risk of virologic failure throughout their treatment course, with higher hazards of virologic failure among cisgender women compared with other youth. Maintaining frequent VL monitoring in YLWH may be warranted, even after prolonged viral suppression.

摘要

与年长的成年人相比,感染艾滋病毒的青年(YLWH)实现并维持病毒抑制的可能性较小。虽然治疗指南建议减少对艾滋病毒控制良好的个体进行病毒载量(VL)监测,但该策略对青少年的适用性尚不清楚。我们进行了一项回顾性队列研究,以描述美国一家青少年艾滋病毒诊所2002年至2015年期间YLWH的纵向病毒抑制情况,并确定病毒学失败的发生率和危险因素。我们使用Cox比例风险模型来比较按基线特征分层的病毒学失败风险比(HRs)。研究参与者(n = 365)主要是非洲裔美国人(87%),以及与男性发生性关系的顺性别男性和跨性别女性(80%),大多数(79%)于2002年至2012年开始接受治疗。在接受抗逆转录病毒治疗(ART)的参与者(n = 201)中,88%实现了病毒抑制,其中29%在抑制后中位12.0个月[四分位间距(IQR)6.9 - 22.4]出现病毒学失败。病毒学失败的队列发病率为每1000人年(PY)200例(置信区间[95% CI]:151 - 264),在持续抑制≥2年后的发病率为每1000 PY 113例(95% CI:57 - 227)。在调整了开始接受ART的时间、初始治疗方案类别和队列进入年份后,顺性别女性病毒学失败的风险增加(HR 3.2,95% CI:1.3 - 7.9,p = 0.01)。总之,青年在整个治疗过程中仍面临较高的病毒学失败风险,与其他青年相比,顺性别女性病毒学失败的风险更高。即使在长期病毒抑制后,对YLWH进行频繁的VL监测可能也是必要的。